Since it ends in mab I assume it's a monoclonal antibody. Those are expensive as fuck because they're so difficult to make. I wonder whether we could scale production up to meet pandemic demand.

mabs are not a straight small molecule synth. Scale as much as you want, growing them takes a while even in parallel.

(this is more or less also why vaccine timelines are so long; chicken eggs take a bit of time to get going, and that's the best breeding ground we have!)